最初の治療前のヘリコバクター・ピロリの抗生物質に対する感受性の体系的評価:コホート研究
Bernard Denis1, Laurianne Plastaras1, Izabella Amaritei1
1Department of Gastroenterology, Pasteur Hospital, Colmar, France.
United European gastroenterology journal
|August 21, 2025
まとめ
ヘリコバクター・パイロリ感染に対するPCRベースの抗生物質感受性試験の実施は,効果的なトリプルセラピーを導き,治癒率を改善し,経験的治療と比較してコストを削減します.
科学分野:
- 胃腸内科
- 感染症
- 臨床微生物学
背景:
- 欧州のガイドラインでは,ヘリコバクター・パイロリ治療を開始する前に抗生物質感受性検査を行うことを推奨しています.
- 経験的治療はフランスで標準であり,感受性による治療は珍しくありません.
研究 の 目的:
- 抗生物質感受性検査の実施と結果を評価する.
- H. pyloriの検出と耐性プロファイルのためのPCR,組織学,培養の診断性能を評価する.
主な方法:
- ヒストロジー,PCR,培養によるバイオプシー分析による食道管内視鏡検査の将来性研究.
- ファーストラインのH. pylori治療を開始する前に,体系的な抗生物質感受性検査が行われました.
主要な成果:
- PCRはH. pyloriの診断に高い感度 (99. 7%) を示した.
- クラリトロミシン (22. 6%) とレボフロッキサシン (18. 6%) の高い耐性が見られた.
- 経験的四重ビスムス療法 (81. 3%) と比較して,感受性誘導トリプル療法では,著しく高い根絶率 (98. 1% - 100%) が達成されました.
- PCRベースの戦略は,免疫ヒストケミストリーベースのアプローチよりも費用対効果が高いことが判明しました.
結論:
- PCRベースの,感受性に基づく戦略は,臨床環境で容易に実装できます.
- このアプローチは有効なトリプルセラピーを促進し,実証的な四重ビスムートセラピーを効率とコストで上回ります.
- 培養試験は,患者のサブセットにおける感受性誘導療法において,増加的利益をもたらす.
関連する概念動画
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
01:26Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145
00:57Antibiotic Selection
55.2K
Overview
55.2K
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569